Congress trades

ChampionX Corporation (CHX)

No longer trading under CHX.

16 Congress tradeslast filed Aug 13, 2025

Download on the App StoreGet it on Google Play

Free on iOS and Android

On recordAs of Nov 9, 2026

ChampionX no longer trades under CHX.

The filings below run to Aug 13, 2025.

EarningsQ1 FY2025 · reported Apr 29, 2025

Q1 FY2025: Beat on EPS. Revenue missed by 2.8%.

EPS Q1 FY2025

Reported$0.50
Consensus$0.40

Revenue Q1 FY2025

Reported$864M
Consensus$889M

Beat 3In line 1Miss 2

Every quarter
Companyfrom the company's filings and listing, as of Nov 4, 2026

About ChampionX Corporation

Exchange
NASDAQ
Sector
Energy
Industry
Oil & Gas Equipment & Services
Chief executive
-
Employees
7,100
Listed since
Apr 27, 2018
Market value
$4.9Blast quoted Jul 16, 2025
Price to earnings (12 mo)
-
Net income per share, as reported (12 mo)
-
Dividend yield
1.47%last quoted Jul 16, 2025

www.championx.com

Earnings6 reported quarters

Earnings

QuarterEPSEPS expectedRevenueRevenue expectedResult
Q1 FY2025reported Apr 29, 2025$0.50$0.40$864.5M$889.0MEPS beatRevenue miss
Q4 FY2024reported Feb 4, 2025$0.50$0.47$912.0M$942.1MEPS beatRevenue miss
Q3 FY2024reported Oct 23, 2024$0.44$0.46$906.5M$945.1MEPS missRevenue miss
Q2 FY2024reported Jul 24, 2024$0.37$0.45$893.3M$959.3MEPS missRevenue miss
Q1 FY2024reported Apr 24, 2024$0.50$0.40$922.1M$921.6MEPS beatRevenue in line
Q4 FY2023reported Feb 5, 2024$0.44$0.44$943.6M$948.0MEPS in lineRevenue in line

Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.

Proxy statementas filed for fiscal 2024 · proxy filed Apr 29, 2025

Executive pay

Mr. Somasundaram’s pay as CEO came to $7.8M for fiscal 2024.
ExecutiveSalaryStock awardsOtherTotal
Mr. SomasundaramPresident and Chief Executive Officer$954K$5.5M$1.4M$7.8M
Mr. FisherExecutive Vice President and Chief Financial Officer$652K$1.7M$681K$3.0M
Mr. BryantChief Operating Officer and President, Chemical Technologies$655K$1.3M$573K$2.5M
Mr. MahoneyPresident, Production & Automation Technologies$512K$888K$477K$1.9M
Ms. WrightSenior Vice President, General Counsel and Secretary$485K$888K$432K$1.8M

The summary compensation table from the proxy statement for fiscal 2024, with titles as filed then. Executives who have since left are not shown. Read the filing

STOCK Act16 disclosures of 16 on record · median 37d of the 45 allowed

Congress trades in CHX

MemberTypeActionAmount disclosedSince the tradeTrade dateDisclosedDelay
Lisa C. McClainSpouseStockPurchase$1,001 - $15,000n/aPrice history ends Jul 16, 2025Jun 11, 2025Aug 13, 202563d
Lisa C. McClainSpouseStockSale$1,001 - $15,000n/aPrice history ends Jul 16, 2025Jun 24, 2025Aug 13, 202550d
Josh GottheimerJointStockSale$1,001 - $15,000n/aPrice history ends Jul 16, 2025Apr 7, 2025May 14, 202537d
Gilbert Ray Cisneros, Jr.StockSale$1,001 - $15,000n/aPrice history ends Jul 16, 2025Apr 9, 2025May 6, 202527d
Jonathan L. JacksonJointStockSale$15,001 - $50,000n/aPrice history ends Jul 16, 2025Nov 16, 2023Dec 4, 202318d
Jonathan L. JacksonJointStockPurchase$15,001 - $50,000n/aPrice history ends Jul 16, 2025Sep 19, 2023Nov 1, 202343d
Daniel S. GoldmanStockSale$1,001 - $15,000n/aPrice history ends Jul 16, 2025Jun 29, 2023Aug 13, 202345d
Daniel S. GoldmanStockPurchase$1,001 - $15,000n/aPrice history ends Jul 16, 2025Apr 10, 2023May 19, 202339d
Josh GottheimerJointStockPurchase$1,001 - $15,000n/aPrice history ends Jul 16, 2025Apr 5, 2023May 19, 202344d
Daniel S. GoldmanStockPurchase$1,001 - $15,000n/aPrice history ends Jul 16, 2025Mar 1, 2023Apr 17, 202347d
Susie LeeJointStockSale$1,001 - $15,000n/aPrice history ends Jul 16, 2025Nov 30, 2022Dec 29, 202229d
Josh GottheimerJointStockPurchase$1,001 - $15,000n/aPrice history ends Jul 16, 2025Apr 21, 2022May 16, 202225d
Susie LeeJointStockPurchase$1,001 - $15,000n/aPrice history ends Jul 16, 2025Jan 5, 2021Feb 10, 202136d
Susie LeeJointStockPurchase$1,001 - $15,000n/aPrice history ends Jul 16, 2025Jan 7, 2021Feb 10, 202134d
Susie LeeJointStockPurchase$1,001 - $15,000n/aPrice history ends Jul 16, 2025Jan 12, 2021Feb 10, 202129d
Susie LeeJointStockPurchase$1,001 - $15,000n/aPrice history ends Jul 16, 2025Jan 13, 2021Feb 10, 202128d

We hold no closing prices for any row shown here, so no move is shown. Not investment advice.

A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.

Every Congress trade in CHX filterable by party, chamber, type and account.

Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.

A STOCK Act disclosure gives each trade as a band of dollar values, which we do not narrow, and is due within 45 days of the trade. An option is described by its underlying company's name; its row says it is an option.

Data as of Nov 9, 2026.

Methodology · Guide to Form 4 · Guide to the STOCK Act

Questions

What the filings on CHX show and how current they are.

Which members of Congress have traded CHX?

Lisa C. McClain, Josh Gottheimer, Gilbert Ray Cisneros, Jr., Jonathan L. Jackson, Daniel S. Goldman and Susie Lee disclosed CHX transactions in the filings shown here.

How quickly are CHX trades disclosed?

Congressional disclosures took a median of 37 days, against the 45 the STOCK Act allows.

Related companies

traded by the same members

See every company we track